IMPEL NEUROPHARMA INC·4

Jul 26, 6:04 PM ET

SHREWSBURY STEPHEN B 4

4 · IMPEL NEUROPHARMA INC · Filed Jul 26, 2021

Insider Transaction Report

Form 4
Period: 2021-07-20
SHREWSBURY STEPHEN B
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-07-20+50,00050,000 total
    Exercise: $12.16Exp: 2031-07-19Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 2.0833% of the total shares on August 22, 2021 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION